Clinical Chemistry, Malmö
501 – 510 of 1295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
(
- Contribution to journal › Article
-
Mark
miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
(
- Contribution to journal › Article
-
Mark
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
(
- Contribution to journal › Article
-
Mark
HLA genotyping in the international Type 1 Diabetes Genetics Consortium
(
- Contribution to journal › Article
-
Mark
Susceptibility Loci Associated with Prostate Cancer Progression and Mortality
(
- Contribution to journal › Article
-
Mark
A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam
(
- Contribution to journal › Article
-
Mark
Impact of Recent Screening on Predicting the Outcome of Prostate Cancer Biopsy in Men With Elevated Prostate-Specific Antigen Data From the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden
(
- Contribution to journal › Article
-
Mark
APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C
(
- Contribution to journal › Article
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.
(
- Contribution to journal › Article